Nanocapsules zero in on cancer cells only

Share this content:

Scientists have developed water-soluble polymer shells that deliver destructive material into the nucleus of cancer cells, leaving healthy cells untouched. The degradable nanoscale shells, or “nanocapsules,” are approximately half the size of the smallest bacterium.

Yi Tang, a professor of chemical and biomolecular engineering and a member of the California NanoSystems Institute at the University of California–Los Angeles (UCLA), led the group that created the nanocapsules, which are about 100 nanometers in size. As the team explained in Nanotoday as well as in a statement issued by UCLA, the nanocapsules release the protein complex apoptin to the innermost part of the tumor cell, where it accumulates. Apoptin induces apoptosis, or programmed self-destruction of the cell.

The process does not present the risk of genetic mutation posed by gene therapy, nor does it damage healthy cells as occurs in chemotherapy, according to the researchers. The shells, developed under mild physiological conditions so as not to alter the chemical structure of the proteins, degrade harmlessly in noncancerous cells.

Tang's team reported that in tests done on human breast cancer cell lines implanted in laboratory mice, tumor growth was significantly reduced after the nanocapsules were delivered.


You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs